Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis
Jun Itakura(Musashino Red Cross Hospital), Tatsuya Kanto(National Center for Global Health and Medicine), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Norifumi Kawada(The University of Osaka), Hiroko Setoyama(Japan Organization of Occupational Health and Safety), Naoya Sakamoto(Chibaken Saiseikai Narashino Hospital), Noriko Oza(Kanazawa University), Junko Tanaka(Hiroshima University), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Namiki Izumi(Musashino Red Cross Hospital), Shuichi Kaneko(Kanazawa University), Masayuki Kurosaki(Musashino Red Cross Hospital), Nobuyuki Enomoto(The Japanese Society of Gastroenterological Surgery), Masaaki Korenaga(National Center for Global Health and Medicine), Shuhei Nishiguchi(Osaka City General Hospital), Tetsuro Simakami(Saga-Ken Medical Centre Koseikan), Motohiko Tanaka(Kumamoto University), Takuji Torimura(Omuta hospital)
Cited by 59
Related Papers
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664